File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Book Chapter: Animal Models of Diabetic Retinopathy (Part 2)

TitleAnimal Models of Diabetic Retinopathy (Part 2)
Authors
KeywordsAnimals
Blood glucose
Blindness
Diabetic complications
Diabetes mellitus/pathology/physiopathology
Issue Date2018
PublisherIntechOpen.
Citation
Animal Models of Diabetic Retinopathy (Part 2). In Bartholomew, I (Eds.), Experimetnal Animal Models of Human Diseases – An Effective Therapeutic Strategy, p. 41-68. London, UK: IntechOpen, 2018 How to Cite?
AbstractDiabetic retinopathy (DR) is one of the leading causes of preventable vision impairment and blindness in the working-age population worldwide. Numerous animal models have been developed for therapeutic drug screening and to further increase our understanding of the molecular and cellular pathological processes involved in DR. Following our discussion of mouse models in “Animal Models of Diabetic Retinopathy Part 1,” we describe the cellular, molecular, and morphological features of both rodent and nonrodent models of DR and their respective advantages and limitations in this chapter. To date, no animal model can holistically reproduce the pathological progression of human DR; most only display early or advanced lesions of DR. However, a thorough understanding of genotypic and phenotypic expressions of existing models will facilitate researchers’ selection of the appropriate model to simulate their desired clinical scenarios.
Persistent Identifierhttp://hdl.handle.net/10722/265944
ISBN

 

DC FieldValueLanguage
dc.contributor.authorTang, LHC-
dc.contributor.authorWong, YHI-
dc.contributor.authorLo, ACY-
dc.date.accessioned2018-12-17T02:14:09Z-
dc.date.available2018-12-17T02:14:09Z-
dc.date.issued2018-
dc.identifier.citationAnimal Models of Diabetic Retinopathy (Part 2). In Bartholomew, I (Eds.), Experimetnal Animal Models of Human Diseases – An Effective Therapeutic Strategy, p. 41-68. London, UK: IntechOpen, 2018-
dc.identifier.isbn9781789231656-
dc.identifier.urihttp://hdl.handle.net/10722/265944-
dc.description.abstractDiabetic retinopathy (DR) is one of the leading causes of preventable vision impairment and blindness in the working-age population worldwide. Numerous animal models have been developed for therapeutic drug screening and to further increase our understanding of the molecular and cellular pathological processes involved in DR. Following our discussion of mouse models in “Animal Models of Diabetic Retinopathy Part 1,” we describe the cellular, molecular, and morphological features of both rodent and nonrodent models of DR and their respective advantages and limitations in this chapter. To date, no animal model can holistically reproduce the pathological progression of human DR; most only display early or advanced lesions of DR. However, a thorough understanding of genotypic and phenotypic expressions of existing models will facilitate researchers’ selection of the appropriate model to simulate their desired clinical scenarios.-
dc.languageeng-
dc.publisherIntechOpen.-
dc.relation.ispartofExperimetnal Animal Models of Human Diseases – An Effective Therapeutic Strategy-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectAnimals-
dc.subjectBlood glucose-
dc.subjectBlindness-
dc.subjectDiabetic complications-
dc.subjectDiabetes mellitus/pathology/physiopathology-
dc.titleAnimal Models of Diabetic Retinopathy (Part 2)-
dc.typeBook_Chapter-
dc.identifier.emailWong, YHI: wongyhi@hku.hk-
dc.identifier.emailLo, ACY: amylo@hku.hk-
dc.identifier.authorityWong, YHI=rp01467-
dc.identifier.authorityLo, ACY=rp00425-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.5772/intechopen.70589-
dc.identifier.spage41-
dc.identifier.epage68-
dc.publisher.placeLondon, UK-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats